Advancing Biophysical Characterisation Technologies to Decode Challenging Membrane Targets & Increase Confidence in Drug Discovery
1:30 pm - Thursday 14th January 2027
- Master emerging techniques for detecting small molecule binding to GPCRs and membrane proteins, overcoming the characterisation challenges that plague these high-value targets representing 30% of marketed drugs
- Learn how nanodisc technologies preserve native protein conformations and enable structural studies, improving the physiological relevance of your biophysical data and reducing false positives
- Discover strategies to stabilise dynamic GPCR conformations using conformer technology and nanobodies, enabling structure determination of specific functional states for agonist versus antagonist design
